TY - JOUR
T1 - The heme oxygenase/biliverdin reductase system as effector of the neuroprotective outcomes of herb-based nutritional supplements
AU - Mhillaj, E.
AU - Cuomo, V.
AU - Trabace, L.
AU - Mancuso, Cesare
PY - 2019
Y1 - 2019
N2 - Over the last few years, several preclinical studies have shown that some herbal products, such as ferulic acid, Ginkgo biloba, and resveratrol, exert neuroprotective effects through the modulation of the heme oxygenase/biliverdin reductase system. Unfortunately, sufficient data supporting the shift of knowledge from preclinical studies to humans, particularly in neurodegenerative diseases, are not yet available in the literature. The purpose of this review is to summarize the studies and the main results achieved on the potential therapeutic role of the interaction between the heme oxygenase/biliverdin reductase system with ferulic acid, G. biloba, and resveratrol. Some critical issues have also been reported, mainly concerning the safety profile and the toxicological sequelae associated to the supplementation with the herbs mentioned above, based on both current literature and specific reports issued by the competent Regulatory Authorities.
AB - Over the last few years, several preclinical studies have shown that some herbal products, such as ferulic acid, Ginkgo biloba, and resveratrol, exert neuroprotective effects through the modulation of the heme oxygenase/biliverdin reductase system. Unfortunately, sufficient data supporting the shift of knowledge from preclinical studies to humans, particularly in neurodegenerative diseases, are not yet available in the literature. The purpose of this review is to summarize the studies and the main results achieved on the potential therapeutic role of the interaction between the heme oxygenase/biliverdin reductase system with ferulic acid, G. biloba, and resveratrol. Some critical issues have also been reported, mainly concerning the safety profile and the toxicological sequelae associated to the supplementation with the herbs mentioned above, based on both current literature and specific reports issued by the competent Regulatory Authorities.
KW - Ferulic acid
KW - Ginkgo biloba
KW - Heme oxygenase
KW - Neuroprotection
KW - Resveratrol
KW - Ferulic acid
KW - Ginkgo biloba
KW - Heme oxygenase
KW - Neuroprotection
KW - Resveratrol
UR - https://publicatt.unicatt.it/handle/10807/147633
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85075600377&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85075600377&origin=inward
U2 - 10.3389/fphar.2019.01298
DO - 10.3389/fphar.2019.01298
M3 - Article
SN - 1663-9812
VL - 10
SP - 1
EP - 11
JO - Frontiers in Pharmacology
JF - Frontiers in Pharmacology
IS - Novembre
ER -